Latest pancreatic cancer News | Page 4

Drug that targets scar-like tissue in tumours shows promise
6 things to know about pancreatic cancer 18 August
Gene-editing tool helps target small cancer-linked mutations
Greens introduce bill to expand presumptive cancer scheme for Victorian firefighters
Surviving lung cancer is just beginning
NSW new $25 million boost to support those living with hard-to-treat cancers
Peptomyc Announces the Approval of Its Phase 1b Trial Testing OMO-103 in Combination With Standard of Care in PDAC Patients
Enhertu demonstrated clinically meaningful progression-free survival and overall survival across multiple HER2-expressing advanced solid tumours in DESTINY-PanTumor02 Phase II trial
$25 million boost to support those living with hard to treat cancers 
Firefighter cancer scheme would be expanded under Greens’ bill
Enhertu demonstrated clinically meaningful and durable responses in patients across multiple HER2-expressing advanced solid tumours
Cancers in distant organs alter liver function
AstraZeneca will highlight momentum of practice-changing cancer medicines across its robust pipeline at ASCO 2023
Oncosil Medical announces first patient treatment in Italy
Pancreatitis cases keep on ICUs
Deficiency causes appetite for meat
Amplia Therapeutics says third cohort enrolment completed in ACCENT clinical trial
Researcher shares his reason to run in HBF Run for a Reason
Researchers image live drug response and resistant ‘pockets’
First patient on trial in colorectal, gastric and ovarian cancer study
Pancreatic cancer carers sought for QIMR Berghofer study
Leading way in care for our firefighters
License agreement with KYM Biosciences for CMG901, a Claudin-18.2 antibody drug conjugate, completed
70 years of scientific excellence has brought significant benefits to Australia
Crucial medical research gets green light
Exposing tumours to bacteria converts immune cells to cancer killers
Exposing cancers to bacteria reminds first responder immune
Enhertu showed clinically meaningful and durable responses across multiple HER2-expressing tumour types in DESTINY-PanTumor02 Phase II trial
New conversations series to explore big questions and new frontiers
UNSW researchers receive more than $5.9m in Cancer Institute NSW grants
Eliminating partners of cancer
Australia Day honour for WEHI president
Ozempic helps people lose weight. But who should be able to use it?
Expansion of Prescribed Cancers List for Firefighters
Potential therapy for aggressive type of colon cancer shows promise
UNSW researchers receive more than $16m in Ideas Grants
$8 million awarded to UniSA researchers to tackle cancer, medicine harm, vascular disease and miscarriages
NHMRC awards Ideas Grants to Garvan researchers
Ask us anything. Pancreatic cancer
Pancreas models may save life
New chair for Destination NSW
Vaccination with senescent cells reduced tumor formation in mice
Funding Boost Supporting Cancer Research Leaders
Ludwig Chicago nanotechnology indicues therapeutic immune responses against multiple types of tumors
Resignation of Cr John Watson
Annual Report 2021-22
Researchers awarded five NHMRC Investigator Grants
Baylor College of Medicine recruiting volunteers for pancreatic cancer clinical trial